Neuronal Death in Amyotrophic Lateral Sclerosis (ALS): What Can We Learn from Genetics?

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|9|3|259-267

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.9, Iss.3, 2010-07, pp. : 259-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Autophagy: What can be Learned from the Genetic Forms of Amyotrophic Lateral Sclerosis

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 3, 2010-07 ,pp. : 268-278

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Alcoholic Steatohepatitis: What Can We Learn from Animal Models?

By  

Current Medicinal Chemistry, Vol. 19, Iss. 9, 2012-03 ,pp. : 1389-1404

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabis in the Arm: What Can we Learn from Intravenous Cannabinoid Studies?

By  

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 4906-4914

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Targeting of Epigenetic Components in Amyotrophic Lateral Sclerosis (ALS)

By  

Current Medicinal Chemistry, Vol. 21, Iss. 31, 2014-10 ,pp. : 3576-3582

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical investigation of medicinal products for treatment of amyotrophic lateral sclerosis (ALS)

By  

European Neuropsychopharmacology, Vol. 11, Iss. 2, 2001-04 ,pp. : 187-189

Elsevier

Access to resources Recommend Favorite